Control of mitogen-induced transformation: characterization of a splenic suppressor cell and its mode of action.
D000818:Animals; D002478:Cells, Cultured; D003208:Concanavalin A; D003513:Cycloheximide / Q000494:pharmacology; D004247:DNA / Q000096:biosynthesis; D003609:Dactinomycin / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D007165:Immunosuppression Therapy; D037102:Lectins; D008213:Lymphocyte Activation; D051379:Mice; D008934:Mitogens; D008937:Mitomycins / Q000494:pharmacology; D008938:Mitosis / Q000187:drug effects; D014176:Protein Biosynthesis; D012313:RNA / Q000096:biosynthesis; D013154:Spleen / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology*
D037102:Lectins; D008934:Mitogens; D008937:Mitomycins; D003208:Concanavalin A; D003609:Dactinomycin; D012313:RNA; D004247:DNA; D003513:Cycloheximide